|
Clinical benefit of tucatinib after isolated brain progression: A retrospective pooled analysis of tucatinib phase 1b studies in HER2+ breast cancer. |
|
|
Consulting or Advisory Role - Daiichi Sankyo; Genentech |
Research Funding - Daiichi Sankyo; Genentech/Roche; Merrimack (Inst); Oncothyreon (Inst) |
Travel, Accommodations, Expenses - Genentech/Roche; Oncothyreon |
|
|
Consulting or Advisory Role - Cascadian Therapeutics (Inst); Flatiron Health; Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst) |
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); BerGenBio (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Curis (Inst); eFFECTOR Therapeutics (Inst); Eisai (Inst); Fujifilm (Inst); Genentech/Roche (Inst); H3 Biomedicine (Inst); Hutchison MediPharma (Inst); Immunomedics (Inst); Kadmon (Inst); Lilly (Inst); Lycera (Inst); Macrogenics (Inst); Mallinckrodt (Inst); MedImmune (Inst); Medivation (Inst); Mersana (Inst); Merus (Inst); Millennium (Inst); Novartis (Inst); Nucana (Inst); OncoMed (Inst); Pfizer (Inst); PharmaMar (Inst); Radius Health (Inst); Rgenix (Inst); Stem CentRx (Inst); Syndax (Inst); Takeda (Inst); TapImmune Inc. (Inst); Tesaro (Inst); TetraLogic Pharmaceuticals (Inst); Verastem (Inst); Zymeworks (Inst) |
|
|
Honoraria - Amgen; Astellas Oncology; Bayer; Pfizer |
Consulting or Advisory Role - Janssen; Novartis; Roche |
Research Funding - Abbvie (Inst); Alethia Biotherapeutics (Inst); Astellas Oncology (Inst); AstraZeneca (Inst); Cascadian Therapeutics (Inst); Celldex (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; Novartis |
|
|
Consulting or Advisory Role - Abbvie; Amgen; Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; Celgene; Lundbeck; Merck; Novartis; Roche; Shire |
Research Funding - Cascadian Therapeutics (Inst); EMD Serono (Inst); Merck (Inst); Novartis (Inst) |
|
|
Honoraria - bioTheranostics |
Consulting or Advisory Role - bioTheranostics |
Research Funding - bioTheranostics (Inst); Cascadian Therapeutics (Inst); Genentech (Inst); Novartis (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - bioTheranostics |
|
|
No Relationships to Disclose |
|
|
Employment - Cascadian Therapeutics |
Stock and Other Ownership Interests - Cascadian Therapeutics |
|
|
Research Funding - Abbott/AbbVie (Inst); Advaxis (Inst); Galena Biopharma (Inst); Incyte (Inst); Merrimack (Inst); Oncothyreon (Inst) |